Indutrade agrees to buy Polish life science firm Sinmed
Swedish group Indutrade has agreed to acquire all shares of Poland's Sinmed, which has annual sales of about PLN 50 million. Closing is expected in Q4 2026.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Swedish technology group Indutrade has signed an agreement to take over all shares of the Polish company Sinmed Sp. z o.o. According to TradingView, citing Indutrade's press release, Sinmed generates annual sales of roughly PLN 50 million, or about SEK 130 million. The firm makes single-use products and medical consumables, including items for anaesthesiology and patient hygiene, positioners and fixation products. Its customers include hospitals, universities, healthcare providers and medtech distributors. Sinmed was founded in 2016, is based in Przyszowice and employs 48 people.
Closing depends on approval from the Polish competition authority and is expected in Q4 2026. Once completed, Sinmed will join Indutrade's Life Science business area. The deal is Indutrade's twelfth acquisition in 2026, and the company expects it to have a marginally positive effect on earnings per share.
why it matters
For Indutrade investors the deal looks routine, since the target is small compared with the group's SEK 32.2 billion in net sales for 2025. The decision of the Polish competition authority is the key milestone to watch. Overall, the transaction reflects Indutrade's strategy of growing through acquisitions of small companies in niche segments.
tags
instruments
sources
- Indutrade (INDT) To Acquire Polish Life Science Firm Sinmed — TradingView, 21 October 2026 at 07:30 UTC
- Indutrade acquires Polish life science company Sinmed — TradingView, 21 October 2026 at 07:30 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗